Featured

Patients and Doctors Deserve the Ability to Consider Whether Aducanumab Will Deliver the Best Medical Outcome and Quality of Life Washington, DC (June 7, 2021) – John Dwyer, President of the Global Alzheimer’s Platform Foundation (GAP), a patient-centric organization committed to accelerating the discovery of therapies for the treatment of Alzheimer’s, issued the following statement on […]

GAP-Net Site, The Cognitive and Research Center of New Jersey, talks about their participation in the GREEN MEMORY trial. The Alzheimer’s Drug, Oligomannate, approved in China and derived from seaweed, is now being studied in the U.S. in a Phase 3, multi-center clinical trial that is actively recruiting participants.  Oligomannate, a drug made from seaweed […]

GAP-Net site Brigham and Women’s Hospital spoke to BioSpace about the emerging data in Alzheimer’s research and what that means for treatments. There may be nothing quite as gut-wrenching as sitting at the bedside of a loved one, watching helplessly as their life comes to an end. Perhaps the only thing more painful is when […]

2020 Citizen Scientist Awards National Cornerstone Honoree Dr. Collins Lewis was featured in the St. Louis Times for his participation in Alzheimer’s clinical trials. NATIONAL CITIZEN SCIENTIST CORNERSTONE AWARD The Global Alzheimer’s Platform Foundation® (GAP) has recognized St. Louis psychiatrist Dr. Collins Lewis as the honoree of the National Citizen Scientist Cornerstone Award®. The Charles […]

2020 Citizen Scientist National Collaborator Awardee, Rep. Matt Willhite from GAP-Net site JEM Research Institute, was featured for his involvement and support for his mother’s Alzheimer’s clinical trial. The Global Alzheimer’s Platform Foundation (GAP) has recognized State Rep. Matt Willhite (D-District 86) as the honoree of the National Citizen Scientist Collaborator Award. JEM Research Institute, […]

GAP-Net site ADMDC at Lifespan Rhode Island Hospital’s citizen scientist nominees were featured about their involvement, as well as GAP President John Dwyer. The Alzheimer’s Disease and Memory Disorders Center (ADMDC) at Lifespan Rhode Island Hospital, a national leader in Alzheimer’s disease care and research, has nominated five clinical trial volunteers for the Global Alzheimer’s Platform Foundation’s (GAP) 2020 National Citizen Scientists Awards®. These […]

2020 Citizen Scientist Catalyst Award Honoree, Dennis Chan, was interviewed on his involvement with Alzheimer’s clinical trials and why it’s important to him. When Dennis Chan’s wife started to struggle with memory loss, the family began a quest to learn more. They began seeking more information about Alzheimer’s disease — a progressive disease that leads […]

A 2020 Citizen Scientist Award Nominee wrote an opinion piece on her reason for getting involved in Alzheimer’s clinical trials and how her trial was her saving grace during the COVID-19 pandemic. Ann Bellotti is a former clinical social worker and an Alzheimer’s clinical trial volunteer at the Alzheimer’s Disease and Memory Disorders Center (ADMDC) […]

Citizen Scientist Nominee, Florida state Representative Matthew Willhite, writes about his mother’s experience with Alzheimer’s disease and GAP-Net site, JEM Research Institute. Before she was diagnosed with Alzheimer’s disease, my mom was a nurse for 30 years. Her compassion for others and her tireless strength inspired me to become a Navy corpsman, a firefighter, a […]

GAP-Net site Cleveland Clinic is hosting the Cleveland Walk to End Alzheimer’s on October 4, 2020. Guest columnist Caroline James is the Business Development Specialist at Independence Village & StoryPoint Avon Lake and Retention Chair for the Cleveland Walk to End Alzheimer’s. I’ve worked in senior care for seven years, often helping those with dementia or Alzheimer’s […]

GAP President John Dwyer was featured in ACRP about what clinical trials need to be doing to increase awareness and hasten treatments. The clinical trial industry continues to grapple with finding new and more effective ways to expand its efforts to combat Alzheimer’s. The obstacles are real. Alzheimer’s trials cost more per patient than trials […]

GAP President, John Dwyer, was featured in a Wall Street Journal article on the importance of Black, African-American, Hispanic and Latinx communities being aware of and enrolling in Alzheimer’s clinical trials, and what GAP is doing to help. Brian Van Buren applied to five Alzheimer’s disease clinical trials after being diagnosed with mild cognitive impairment […]

Below is a press release from GAP-Net site, Okanagan Clinical Trials, regarding a high profile member of the community completeing a memory assessment. Kelowna (July 21, 2020) – Maxine Dehart, local city councillor, hotelier and journalist, decided to book a memory assessment for herself after featuring Okanagan Clinical Trials as part of her Straight from DeHart column in May. […]

GAP President John Dwyer wrote a piece in The Hill urging Congress to ensure research centers involved in Alzheimer’s clinical trials will have access to COVID-19 relief funds. COVID-19 has had a devastating impact on clinical trials and the medical research infrastructure that scientists depend upon to develop new drugs for Alzheimer’s and all the diseases we fear most. Without action, […]

Alice Bailey, a GAP Citizen Scientist Award nominee, wrote an Op-Ed piece in the Cambridge Chronicle about her experience as an Alzheimer’s patient and clinical trial volunteer. For many seniors, Alzheimer’s disease is surrounded by fear. Fear of the diagnosis can be so strong that some don’t want to learn about or talk about the […]

GAP President John Dwyer and GAP-Net Site Roper St. Francis Healthcare Research and Innovation Center in Charleston, South Carolina were featured on LIVE 5 WCSC News about the need for Alzheimer’s clinical trials to begin again. CHARLESTON, S.C. (WCSC) – Medical experts are worried that the COVID-19 pandemic has put delays on the search for […]

GAP President John Dwyer was quoted in AlzForum about the challenges and changes in Alzheimer’s clinical trials due to COVID-19. As Alzheimer’s research comes to, scientists are taking stock of the damage. In the academic world, the main cost was time (see Part 1 of this story). For most clinical studies, the damage was more tangible, with […]

June 2, 2020 The events that spurred the reaction around the country this weekend are painful reminders that injustice remains in our world. At the Global Alzheimer’s Platform Foundation® (GAP), we agree that monumental changes on local and national levels are necessary to address the issues plaguing Black and African American people in our country […]

GAP-Net Site, the University of Kansas Alzheimer’s Disease Center’s (KU ADC) Outreach, Recruitment and Education Core earned the 2020 University of Kansas Medical Center Diversity, Equity and Inclusion Award. The University of Kansas Alzheimer’s Disease Center’s Outreach, Recruitment and Education Core earned the 2020 University of Kansas Medical Center Diversity, Equity and Inclusion Award. Presented […]